A

Alaunos Therapeutics Inc
NASDAQ:TCRT

Watchlist Manager
Alaunos Therapeutics Inc
NASDAQ:TCRT
Watchlist
Price: 2.84 USD 0.71% Market Closed
Market Cap: 4.7m USD

Intrinsic Value

TCRT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one TCRT stock under the Base Case scenario is 0.08 USD. Compared to the current market price of 2.84 USD, Alaunos Therapeutics Inc is Overvalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TCRT Intrinsic Value
0.08 USD
Overvaluation 97%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Alaunos Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
TCRT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for TCRT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Alaunos Therapeutics Inc
NASDAQ:TCRT
US
Biotechnology
Market Cap
4.5m USD
IPO
Aug 20, 2004
US
Biotechnology
Market Cap
4.5m USD
IPO
Aug 20, 2004
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Alaunos Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alaunos Therapeutics Inc

Current Assets 2.8m
Cash & Short-Term Investments 1.1m
Receivables 5k
Other Current Assets 1.7m
Efficiency

Free Cash Flow Analysis
Alaunos Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Alaunos Therapeutics Inc

Revenue
10k USD
Operating Expenses
-4.8m USD
Operating Income
-4.8m USD
Other Expenses
133k USD
Net Income
-4.7m USD
Fundamental Scores

TCRT Profitability Score
Profitability Due Diligence

Alaunos Therapeutics Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

12/100
Profitability
Score

Alaunos Therapeutics Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

TCRT Solvency Score
Solvency Due Diligence

Alaunos Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
60/100
Solvency
Score

Alaunos Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TCRT Price Targets Summary
Alaunos Therapeutics Inc

There are no price targets for TCRT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Alaunos Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TCRT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TCRT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TCRT stock?

The intrinsic value of one TCRT stock under the Base Case scenario is 0.08 USD.

Is TCRT stock undervalued or overvalued?

Compared to the current market price of 2.84 USD, Alaunos Therapeutics Inc is Overvalued by 97%.

Back to Top